Leverage cutting-edge AI technology to design enzymes that streamline drug development, enhance yields, and reduce production costs
Transforming Pharmaceutical Enzyme Engineering with AI
Enzymes are at the core of many pharmaceutical processes, from drug synthesis to biocatalysis. They enable the creation of highly specific reactions, driving efficiency and reducing waste. However, traditional enzyme engineering methods often fall short in meeting the increasing complexity and scalability demands of modern drug development.
Property visualization
Why AI-Powered Enzyme Engineering?
Our AI-driven platform revolutionizes enzyme engineering by harnessing advanced computational models to create tailored enzyme solutions
- Accelerated DevelopmentReduce enzyme design timelines by up to 75%
- Enhanced PrecisionAchieve targeted modifications for optimal enzyme activity
- Cost-EffectivenessLower production costs through more efficient enzyme use
- SustainabilityDevelop green solutions to reduce environmental impact
Applications in the Pharmaceutical Industry
Our AI-powered enzymes are designed for diverse pharmaceutical applications, enabling precision, efficiency, and scalability in every process
Drug Synthesis
Biocatalysis
Active Pharmaceutical Ingredients (APIs)
Precision Medicine
Why Choose Us?
With a unique combination of AI expertise and pharmaceutical insights, we deliver enzyme solutions tailored to your specific needs
Advanced AI models for enzyme optimization
Expertise in pharmaceutical processes
Commitment to sustainability and innovation
Optimization of cellulase variants
Frequently Asked Questions (FAQs)
Our solutions leverage advanced artificial intelligence and machine learning to design, optimize, and engineer enzymes tailored to your specific applications. Whether you need enhanced catalytic efficiency, improved stability, or novel enzyme functionalities, our platform streamlines the design process, reduces experimental iterations, and accelerates time-to-market.
Our services are ideal for biotechnology and pharmaceutical companies, industrial manufacturers, academic research labs, and any organization involved in enzyme applications. Industries such as biofuels, food processing, personal care, paper and pulp, and environmental management can all benefit from our AI-driven enzyme engineering tools.
Our process begins with your input data—such as enzyme sequences, structural information, and target reaction profiles. Our proprietary AI algorithms generate a library of enzyme variants and use predictive modeling to evaluate their catalytic activity, stability, and specificity. The top-performing candidates are ranked and provided for further experimental validation, significantly reducing the number of lab iterations needed.
Our platform is versatile and can be applied to a wide range of enzymes including hydrolases, oxidoreductases, transferases, and lyases. We focus on both enhancing the performance of existing enzymes and designing entirely new biocatalysts for applications in industrial processes, therapeutics, and research.
Absolutely. We collaborate with you to tailor our AI models and parameters to meet your project’s unique requirements. This includes integrating your proprietary data, adjusting target properties, and aligning the enzyme design with your process conditions to deliver a highly customized solution.
Our software features robust API support and data export options (e.g., CSV, JSON) that enable seamless integration with Laboratory Information Management Systems (LIMS) and other data analytics pipelines. We also offer comprehensive onboarding, training, and technical support to ensure smooth adoption by your team.
Our models are trained on extensive datasets from scientific literature and experimental data. Continuous feedback from laboratory validations helps refine our predictions. Although our AI predictions are highly reliable, we recommend in vitro or in vivo validation to confirm the performance of the engineered enzymes under your specific conditions.
Yes, we provide collaborative support during the validation phase. Our team can assist in designing proof-of-concept studies, advising on experimental protocols, and interpreting validation results to ensure that the engineered enzymes meet your performance criteria.
Our pricing is flexible and depends on the scope, duration, and level of customization required for your project. We offer subscription-based models for ongoing research and project-based pricing for specific campaigns. Please contact us for a personalized consultation and detailed quote.
Our dedicated customer support team is available throughout your journey—from initial consultation and onboarding to ongoing technical support and regular software updates. We offer multiple support channels including email, phone, live chat, and detailed documentation to ensure your success.
Revolutionize Pharma with AI Enzyme Engineering
Start your journey toward efficient, sustainable, and innovative pharmaceutical production with our AI-powered enzyme solutions
Neoncorte Bio
Where AI Meets Biotechnology
Neoncorte Bio is at the forefront of the convergence between artificial intelligence and enzyme engineering. Our team comprises experts in computational biology, bioinformatics, and machine learning, all driven by a mission to accelerate innovation in enzyme design. By leveraging our advanced AI models, we provide unparalleled solutions that enhance efficiency, reduce costs, and push the boundaries of what's possible in enzyme engineering
Publications
Scientific Publication of Neoncorte Bio Team
- Modification of natural enzymes to introduce new properties and enhance existing ones is a central challenge in bioengineering. This study is focused on the development of Taq polymerase mutants that show enhanced reverse transcriptase (RTase) activity while retaining other desirable properties such as fidelity, 5′-3′ exonuclease activity, effective deoxyuracil incorporation, and tolerance to locked nucleic acid (LNA)-containing substrates.
- The transcriptomic data are being frequently used in the research of biomarker genes of different diseases and biological states. The most common tasks there are the data harmonization and treatment outcome prediction. Both of them can be addressed via the style transfer approach. Either technical factors or any biological details about the samples which we would like to control (gender, biological state, treatment, etc.) can be used as style components.
- List of all Neoncorte Bio publications dedicated to Molecular Biology, Biotechnology, Artificial Intelligence and Artificial Neural Networks, published mostly by Nikolay Russkikh, CEO of Neoncorte Bio
Our Expertise in Action
With extensive experience in AI applications and software engineering tailored to the life sciences, we specialize in solving complex challenges and delivering innovative solutions for our customers. Our work demonstrates a deep understanding of cutting-edge technologies and their application in the real world.
Here are examples of the types of projects we have successfully delivered:
Here are examples of the types of projects we have successfully delivered:
- Automated NGS Data Analysis:Designed a production-grade solution for the automated processing, annotation, and analysis of Next-Generation Sequencing (NGS) data.
- Single-Cell Data Integration:Built state-of-the-art tools for integrating multimodal single-cell data, achieving recognition for technical excellence.
- Metagenomic Classification Algorithms:Developed advanced methods for classifying sequencing reads in metagenomics research.
- High-Throughput Image Processing Pipelines:Engineered an efficient pipeline to process millions of sequencing images with exceptional accuracy.
- Cell Counting via AI:Created a computer vision solution for precise cell counting in microphotography images, streamlining data analysis.
Who we are?
Get in touch with our team
Phone: +1-503-754-3958
Email: contact@neoncorte.com
Email: contact@neoncorte.com
All Rights Reserved. Neoncorte Bio. ©2024-2025
contact@neoncorte.com
contact@neoncorte.com